A7MEW8 Nicotinate phosphoribosyltransferase MolNFT, Molecular NFT on GenesisL1

Nicotinate phosphoribosyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeieudxkysqoyot5b7atufqk2jlzi2ajmqrw3ycbutazk2gxy5kspvu/metadata.json

IPFS of structure file:

bafybeid66g3jd6f2lz37w6anyy7z2wsrqji32e2okjafx5hgom6ffro5zy/AF-A7MEW8-F1-model_v2.pdb

First NFT owner address (eip-55):

0xF8cD1d8d93E9783063700De244A6e3cf6A195579

First NFT owner address (bech32):

genesis1lrx3mrvna9urqcmsph3yffhrea4pj4tedrk7yh

Current NFT ID #303693 owner (web3):

0x02Ec5621A2d2D4f60b03875D3630DEF810B088E5

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
303693
Accession (UniProt):
A7MEW8
Name::
Nicotinate phosphoribosyltransferase
Experimental Method:
Predicted structure
Sequence source:
Cronobacter sakazakii (strain ATCC BAA-894)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A7MEW8 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A7MEW8|PNCB_CROS8 Nicotinate phosphoribosyltransferase OS=Cronobacter sakazakii (strain ATCC BAA-894) OX=290339 GN=pncB PE=3 SV=1 MTQYASPLLQTLLDTDAYKLHMQQAVFHHYYDVHVAAEFRCRGDDLLGIYADAIREQVDAMQHLALSDAEYQWLSGLPFFKSDYLQWLKTFRYDPTQVQIRNDGGKLDIRLSGPWREVIMWEVPLLAVISELVHRYRSPEASVDQALAHLEVKLDDFRTMTDGLDLSAFRLMDFGTRRRFSRDVQQAIVERLKLEPWFIGTSNYDLARRLSLTPMGTQAHEWFQAHQQISPDLANSQIAALQAWLDEYPDMLGIALTDCITMDAFLRDFGPEFAGRYQGLRHDSGDPVQWGEKAIAHYQQLGIDPLSKTLIFSDNLDFAKAIELYRHFADRVKLGFGIGTRLTCDIPHVKPLNIVIKLVECNGRPVAKLSDSPGKTICHDKAFVRALRKAFDLPQVRKAS

A7MEW8 AF NFT

MOLNFT AF v1

NFT data

MOLNFT A7MEW8 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience